Notably, Muraro et al. identified an increase in the clonal frequency of EBV reactive T cells at 2 months in a subset of patients post-AHSCT and aforementioned investigations of CD8+CD57+ cells in MS demonstrates that a proportion of these cells are EBV specific (133). The gene discussed is CD8A; the disease is myeloid sarcoma.